Angiotensin I-converting enzyme insertion/deletion polymorphism and adrenergic response to exercise in hypertensive patients

Medical Science Monitor

Volumn 8, Issue 8, 2002, Pages

  Jalil, Jorge E ^a   Córdova, Samuel ^a   Ocaranza, Maria Paz ^a   Schumacher, Erwin ^a   Braun, Sandra ^a   Chamorro, Gastón ^a   Fardella, Carlos ^a   Lavandero, Sergio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adrenergic system; Angiotensin; Angiotensin converting enzyme polymorphism; Catecholamines; Exercise; Hypertension

Indexed keywords

ADRENALIN; ANGIOTENSIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESSENTIAL HYPERTENSION; EXERCISE; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE MASS; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; MALE; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREADMILL EXERCISE; ALLELE; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; ALLELES; CATECHOLAMINES; EXERCISE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM (GENETICS); PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0036686961     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Angiotensin formation and degradation
2. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
3. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE
4. Prevalence of the angiotensin I-converting enzyme insertion/deletion polymorphism, plasma ACE activity and left ventricular mass in normotensive Chilean population
5. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction
6. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
7. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes
8. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes
9. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism
10. Plasma angiotensin-converting enzyme activity and carotid wall thickening
11. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population
12. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study
13. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors
14. A socio-genetic cline in Chilean population
15. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP I) (dipeptidyl carboxypeptidase 1)
16. Studies on the angiotensin converting enzyme with different substrates
17. A sensitive fluoremetric assay for serum angiotensin-converting enzyme
18. Spectrophotometric assay and properties of the angiotensin-converting enzyme level by direct radioimmunoassay
19. Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine as substrate
20. Recommendations regarding quantitation in M - Mode echocardiography: Results of a survey of echocardiographic measurements
21. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy lindings
22. Respuesta adrenérgica al ejercicio dinámico leve en sujetos sanos y en pacientes con insuficiencia cardíaca crónica
23. Effects of captopril versus milrinnone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure
24. Differentiation of neurogenic and myocardial angiotensin 11 receptors in isolated rabbit atria
25. Angiotensin II enhances norepinephrine spillover during sympathetic activation in conscious rabbits
26. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype I receptors
27. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm
28. The interaction between noradrenaline and angiotensin II in man: Evidence for a postsynaptic and against a presynaptic interaction
29. The effect of angiotensin II on endogenous noradrenaline release in man
30. Angiotensin-converting enzyme inhibition and the norepinephrine spillover response to dynamic exercise
31. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects
32. Lack of modulation of the adrenergic response to exercise in essential hypertension during diltiazem therapy
33. Cardiac secretion of atrial natriuretic factor with exercise in chronic congestive heart patients
34. Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy
35. Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure
36. Association of angiotensin converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training
37. Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent
38. VO2 max is associated with ACE genotype in postmenopausal women
39. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in nor-motensive subjects